Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

被引：0

作者：

Naoto Katakami

Tomoya Mita

Hidenori Yoshii

Toshihiko Shiraiwa

Tetsuyuki Yasuda

Yosuke Okada

Keiichi Torimoto

Yutaka Umayahara

Hideaki Kaneto

Takeshi Osonoi

Tsunehiko Yamamoto

Nobuichi Kuribayashi

Kazuhisa Maeda

Hiroki Yokoyama

Keisuke Kosugi

Kentaro Ohtoshi

Isao Hayashi

Satoru Sumitani

Mamiko Tsugawa

Kayoko Ryomoto

Hideki Taki

Tadashi Nakamura

Satoshi Kawashima

Yasunori Sato

Hirotaka Watada

Iichiro Shimomura

机构：

[1] Osaka University Graduate School of Medicine,Department of Metabolic Medicine

[2] Osaka University Graduate School of Medicine,Department of Metabolism and Atherosclerosis

[3] Juntendo University Graduate School of Medicine,Department of Metabolism & Endocrinology

[4] Juntendo Tokyo Koto Geriatric Medical Center,Department of Medicine, Diabetology & Endocrinology

[5] Shiraiwa Medical Clinic,Department of Diabetes and Endocrinology

[6] Osaka Police Hospital,First Department of Internal Medicine, School of Medicine

[7] University of Occupational and Environmental Health,Department of Diabetes and Endocrinology

[8] Japan,Diabetes and Endocrinology

[9] Osaka General Medical Center,Center for Diabetes and Endocrinology

[10] Department of Diabetes,Department of Endocrinology and Metabolism

[11] Endocrinology and Metabolism,Center for Diabetes Mellitus

[12] Kawasaki Medical School,Diabetes Center

[13] Nakakinen Clinic,Department of Internal Medicine

[14] Kansai Rosai Hospital,Department of Preventive Medicine and Public Health

[15] Misaki Naika Clinic,undefined

[16] Kitasenri Maeda Clinic,undefined

[17] Jiyugaoka Medical Clinic,undefined

[18] Kosugi Medical Clinic,undefined

[19] Otoshi Medical Clinic,undefined

[20] Hayashi Clinic,undefined

[21] Nippon Life Hospital,undefined

[22] Ikeda Municipal Hospital,undefined

[23] Osaka Rosai Hospital,undefined

[24] National Hospital Organization Osaka National Hospital,undefined

[25] Kawasaki Hospital,undefined

[26] Kanda Naika Clinic,undefined

[27] Keio University School of Medicine,undefined

来源：

Cardiovascular Diabetology | / 20卷

关键词：

Arterial stiffness; Pulse wave velocity; Arteriosclerosis; Diabetes; SGLT2 inhibitor; Tofogliflozin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
Katakami, Naoto
Mita, Tomoya
Yoshii, Hidenori
Shiraiwa, Toshihiko
Yasuda, Tetsuyuki
Okada, Yosuke
Torimoto, Keiichi
Umayahara, Yutaka
Kaneto, Hideaki
Osonoi, Takeshi
Yamamoto, Tsunehiko
Kuribayashi, Nobuichi
Maeda, Kazuhisa
Yokoyama, Hiroki
Kosugi, Keisuke
Ohtoshi, Kentaro
Hayashi, Isao
Sumitani, Satoru
Tsugawa, Mamiko
Ryomoto, Kayoko
Taki, Hideki
Nakamura, Tadashi
Kawashima, Satoshi
Sato, Yasunori
Watada, Hirotaka
Shimomura, Iichiro
[J]. CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
[2] Effect of Tofogliflozin on Carotid Intima-Media Thickness in Patients with Type 2 Diabetes: Results from the Prospective, Randomized, Open-Label, Parallel-Group Comparative UTOPIA Trial
Katakami, Naoto
Mita, Tomoya
Watada, Hirotaka
Shimomura, Iichiro
[J]. DIABETES, 2020, 69
[3] Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
Katakami, Naoto
Mita, Tomoya
Yoshii, Hidenori
Shiraiwa, Toshihiko
Yasuda, Tetsuyuki
Okada, Yosuke
Torimoto, Keiichi
Umayahara, Yutaka
Kaneto, Hideaki
Osonoi, Takeshi
Yamamoto, Tsunehiko
Kuribayashi, Nobuichi
Maeda, Kazuhisa
Yokoyama, Hiroki
Kosugi, Keisuke
Ohtoshi, Kentaro
Hayashi, Isao
Sumitani, Satoru
Tsugawa, Mamiko
Ryomoto, Kayoko
Taki, Hideki
Nakamura, Tadashi
Kawashima, Satoshi
Sato, Yasunori
Watada, Hirotaka
Shimomura, Iichiro
[J]. CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[4] Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
Naoto Katakami
Tomoya Mita
Hidenori Yoshii
Toshihiko Shiraiwa
Tetsuyuki Yasuda
Yosuke Okada
Keiichi Torimoto
Yutaka Umayahara
Hideaki Kaneto
Takeshi Osonoi
Tsunehiko Yamamoto
Nobuichi Kuribayashi
Kazuhisa Maeda
Hiroki Yokoyama
Keisuke Kosugi
Kentaro Ohtoshi
Isao Hayashi
Satoru Sumitani
Mamiko Tsugawa
Kayoko Ryomoto
Hideki Taki
Tadashi Nakamura
Satoshi Kawashima
Yasunori Sato
Hirotaka Watada
Iichiro Shimomura
[J]. Cardiovascular Diabetology, 19
[5] Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial
Yang, Xue
He, Zhiwei
Yuan, Li
Huang, Wenbin
Li, Doudou
Xiang, Pingping
Chen, Yu
Chen, Guofang
Liu, Chao
[J]. BMC ENDOCRINE DISORDERS, 2023, 23 (01)
[6] Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial
Xue Yang
Zhiwei He
Li Yuan
Wenbin Huang
Doudou Li
Pingping Xiang
Yu Chen
Guofang Chen
Chao Liu
[J]. BMC Endocrine Disorders, 23
[7] The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes A Multicenter, Parallel-Group, Open-Label Randomized Clinical Trial
Poole, Alexis P.
Finnis, Mark E.
Anstey, James
Bellomo, Rinaldo
Bihari, Shailesh
Biradar, Vishwanath
Doherty, Sarah
Eastwood, Glenn
Finfer, Simon
French, Craig J.
Heller, Simon
Horowitz, Michael
Kar, Palash
Kruger, Peter S.
Maiden, Matthew J.
Martensson, Johan
McArthur, Colin J.
McGuinness, Shay P.
Secombe, Paul J.
Tobin, Antony E.
Udy, Andrew A.
Young, Paul J.
Deane, Adam M.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (07) : 874 - 882
[8] Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study
Naoto Katakami
Tomoya Mita
Hidenori Yoshii
Toshihiko Shiraiwa
Tetsuyuki Yasuda
Yosuke Okada
Yutaka Umayahara
Hideaki Kaneto
Takeshi Osonoi
Tsunehiko Yamamoto
Nobuichi Kuribayashi
Kazuhisa Maeda
Hiroki Yokoyama
Keisuke Kosugi
Kentaro Ohtoshi
Isao Hayashi
Satoru Sumitani
Mamiko Tsugawa
Makoto Ohashi
Hideki Taki
Tadashi Nakamura
Satoshi Kawashima
Yasunori Sato
Hirotaka Watada
Iichiro Shimomura
[J]. Diabetes Therapy, 2017, 8 : 999 - 1013
[9] Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study
Katakami, Naoto
Mita, Tomoya
Yoshii, Hidenori
Shiraiwa, Toshihiko
Yasuda, Tetsuyuki
Okada, Yosuke
Umayahara, Yutaka
Kaneto, Hideaki
Osonoi, Takeshi
Yamamoto, Tsunehiko
Kuribayashi, Nobuichi
Maeda, Kazuhisa
Yokoyama, Hiroki
Kosugi, Keisuke
Ohtoshi, Kentaro
Hayashi, Isao
Sumitani, Satoru
Tsugawa, Mamiko
Ohashi, Makoto
Taki, Hideki
Nakamura, Tadashi
Kawashima, Satoshi
Sato, Yasunori
Watada, Hirotaka
Shimomura, Iichiro
[J]. DIABETES THERAPY, 2017, 8 (05) : 999 - 1013
[10] Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
Zhang, Shuo
Zhang, Chuanyan
Chen, Jingxian
Deng, Feiying
Wu, Zezhen
Zhu, Dan
Chen, Fengwu
Duan, Yale
Zhao, Yue
Hou, Kaijian
[J]. FRONTIERS IN PHARMACOLOGY, 2023, 14

← 1 2 3 4 5 →